These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14239406)

  • 21. PHARMACODYNAMICS OF PARENTERAL AND ORAL ANTICOAGULANTS.
    FREMONT RE
    Angiology; 1964 Mar; 15():152-62. PubMed ID: 14130384
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the mechanism of the anticoagulant action of dicomarin and its analogues].
    MACHABELI MS
    Ter Arkh; 1961 Feb; 33():3-10. PubMed ID: 13764808
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative studies on the effect of dicumarol and tromexan on prothrombin level, capillary resistance and capillary permeability].
    LINKE A
    Dtsch Med Wochenschr; 1952 Jun; 77(24):775-80. PubMed ID: 14936621
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulants and cerebral hemodynamics. Action of bishydroxycoumarin.
    KEMPINSKY WH; BONIFACE WR; KEATING JB; WEINSTEN W
    Arch Neurol; 1961 Sep; 5():275-8. PubMed ID: 13752446
    [No Abstract]   [Full Text] [Related]  

  • 25. [Supervision of dicoumarin therapy. Study of the different laboratogs tests].
    SOULIER JP; MANDALAKI T
    Presse Med (1893); 1962 Oct; 70():2041-4. PubMed ID: 13978406
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methods for the control of anticoagulant therapy].
    Lechner K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):129-39. PubMed ID: 4098767
    [No Abstract]   [Full Text] [Related]  

  • 27. THE PREVENTION OF HEMORRHAGE WITH ANTICOAGULANTS--AN EXPLORATORY STUDY OF A PARADOX.
    ROBERTS HR; PENICK GD; WEBSTER WP; BRINKHOUS KM
    Ann N Y Acad Sci; 1964 Jul; 115():67-77. PubMed ID: 14192862
    [No Abstract]   [Full Text] [Related]  

  • 28. ADDITION OF PROTHROMBIN TO BLOOD FROM DOGS RECEIVING DICUMAROL.
    SCHROEER H; HEENE DL; SEEGERS WH
    Thromb Diath Haemorrh; 1965 Mar; 13():187-93. PubMed ID: 14285968
    [No Abstract]   [Full Text] [Related]  

  • 29. Historical notes on the early development of anticoagulant therapy with dicumarol in Sweden.
    LEHMANN J
    Circulation; 1959 Jan; 19(1):122-6. PubMed ID: 13619032
    [No Abstract]   [Full Text] [Related]  

  • 30. ANTICOAGULANT PROPERTIES OF TETRACYCLINES.
    SEARCY RL; FOREMAN JA; MYERS HD; BERGQUIST LM
    Antimicrob Agents Chemother (Bethesda); 1963; 161():471-6. PubMed ID: 14274945
    [No Abstract]   [Full Text] [Related]  

  • 31. LONG-TERM ANTICOAGULANT THERAPY. COMPLICATIONS AND CONTROL IN A REVIEW OF 978 CASES.
    MOSLEY DH; SCHATZ IJ; BRENEMAN GM; KEYES JW
    JAMA; 1963 Dec; 186():914-6. PubMed ID: 14065364
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term anticoagulant therapy.
    FIFER WR; DAHL JC; VENNES JA
    Bull St Louis Park Med Cen; 1963 Feb; 7():9-27. PubMed ID: 13945099
    [No Abstract]   [Full Text] [Related]  

  • 33. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of tolbutamide effect on anticoagulant therapy.
    Poucher RL; Vecchio TJ
    JAMA; 1966 Sep; 197(13):1069-70. PubMed ID: 4162027
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticoagulant therapy. I.
    KUPFER HG
    Va Med Mon (1918); 1963 Mar; 90():143-4. PubMed ID: 13927435
    [No Abstract]   [Full Text] [Related]  

  • 36. Dicumarol as an anticoagulant; use in a large series of cases.
    ALLEN EV; HINES EA
    Trans Assoc Am Physicians; 1947; 60(1 vol):218-26. PubMed ID: 18917262
    [No Abstract]   [Full Text] [Related]  

  • 37. [MYOCARDIAL INFARCT AND THROMBOSIS IN PRACTICE. AMBULANT ANTICOAGULANT THERAPY AND CONTROL OF DEVELOPMENTS. CENTRAL THROMBOSIS SERVICES].
    EDAM K
    Med Welt; 1964 Apr; 16():910-5. PubMed ID: 14196333
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of anticoagulant therapy on serum cholesterol levels.
    WELLS AO; HOLLOMAN JL; WROBLEWSKI F
    J Am Geriatr Soc; 1962 Oct; 10():885-8. PubMed ID: 13999871
    [No Abstract]   [Full Text] [Related]  

  • 39. [TRIALS ON THE CAPILLARY BLOOD METHOD FOR THE CONTROL OF ANTICOAGULANT THERAPY: THE OWREN THROMBOTEST AND HARTERT PROTHROMBIN TIME].
    FISCHER M
    Thromb Diath Haemorrh; 1964 Apr; 11():243-53. PubMed ID: 14167109
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrinolytic activity and anticoagulant drugs].
    BERKARDA B
    Turk Tip Cemiy Mecm; 1963 Mar; 29():135-8. PubMed ID: 13970828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.